Description of the medicine: De-Nol (De-Nol)
Colloidal bismuth subcitrate.
Synonyms: Bismuth tricalium dicitrate, Biscolcitrat, Bismuthate tripotassium dicitrate, De-Noltal, Duosol, Tripotassium dicitrabismutate, Ulceron and others.
Tribimol (Ttibimol) is close in composition and action to the De-nol.
De-nol has an antacid and enveloping effect. When you take the tablets inside gradually forms a colloid mass, distributed on the surface of the mucous membrane of the stomach, envelops parietal cells; Has not only an antacid, but also a cytoprotective effect.
Indications for use are the same as for tablets "Vikalin", "Vicair" and other similar drugs (see Sukralfat, Fosfalugel).
According to the data, de-nol is more effective in the treatment of peptic ulcer of the stomach and duodenum than bismuth nitrate, which is due to its ability to better sanitize the mucous membranes of the stomach and duodenum from pyloric helico (campylo) bacteria. Recently, these pathogens have been given great importance in the pathogenesis of peptic ulcer disease.
Assign de-nol 4 times a day: 1 - 2 tablets for 1/2 - 1 h before breakfast, lunch and dinner and 1 - 2 tablets at bedtime. The course of treatment 4 - 8 weeks.
Usually the drug is well tolerated; Nausea and vomiting are possible. Cal in the treatment of the drug is painted black. It is not recommended to apply the drug in severe disorders of kidney function.
To avoid neurotoxic effects, it is not possible to prescribe the drug for a long time in large doses.
Product: tablets of 0.12 g.